Category Archives: AZBio News
AdvaMed’s Steve Ubl Announces Move to PhRMA
Steve Ubl, president and CEO of AdvaMed will leave his post at AdvaMed in the fall to serve as president and CEO of PhRMA.
Ubl shared the letter below with the AdvaMed Board of Directors on Friday, September 25, 2015.Continue reading
Insys Therapeutics In-Licenses Cannabinoid Inhalation Technology; ExpandsLeadership Team
Partnership Enhances the Position of Insys as Potential Leader in Synthetic Pharmaceutical CannabinoidsContinue reading
LIFE in the Fast Lane: How three Arizona biotech companies are setting the pace
Calimmune, Inc., HTG Molecular Diagnostics, Inc., and VisionGate, Inc. are picking up the pace and when they reach the finish line we all win.Continue reading
Dr. Dan Rudmann Joins Flagship Biosciences as VP of Program Development
Flagship Biosciences continues to expand its leadership position in pathology-focused tissue image analysis with the addition of Dr. Dan Rudmann as Vice President of Program Development.Continue reading